SILEXION THERAPEUTICS CORP Cash and Cash Equivalents
SILEXION THERAPEUTICS CORP (SLXN) had Cash and Cash Equivalents of $2.23 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments › Cash and Cash Equivalent
us-gaap:CashAndCashEquivalentsAtCarryingValue · last filed 2026-08-14
- 2026-06-30: Cash and Cash Equivalents, at Carrying Value $2.23M.
- 2026-03-31: Cash and Cash Equivalents, at Carrying Value $2.41M.
- 2025-12-31: Cash and Cash Equivalents, at Carrying Value $5.99M.
- 2025-09-30: Cash and Cash Equivalents, at Carrying Value $9.24M.
| Period end | Cash and Cash Equivalents, at Carrying Value |
|---|---|
| 2026-06-30 | $2.23M 10-Q · filed 2026-08-14 |
| 2026-03-31 | $2.41M S-1/A · filed 2026-08-10 |
| 2025-12-31 | $5.99M 10-Q · filed 2026-08-14 |
| 2025-09-30 | $9.24M 10-Q · filed 2025-11-12 |
| 2025-06-30 | $3.47M 10-Q · filed 2025-08-12 |
| 2025-03-31 | $6.15M 10-Q · filed 2025-05-13 |
| 2024-12-31 | $1.19M S-1/A · filed 2026-08-10 |
| 2024-09-30 | $1.97M 10-Q · filed 2024-11-14 |
| 2024-06-30 | $1.70M 10-Q · filed 2024-08-29 |
| 2023-12-31 | $4.59M 8-K · filed 2025-08-20 |
| 2023-06-30 | $6.44M 10-Q · filed 2024-08-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |